drugset / Trial / NCT00291642

A Study to Compare the Efficacy of Levocetirizine to Placebo in Reducing Symptoms of Seasonal Allergic Rhinitis (SAR) in Sensitive Subjects Exposed to Ragweed Pollen

NCT00291642

Phase 2 Completed 551 enrolled UCB Pharma
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of the study is to assess the efficacy comparability of cetirizine and levocetirizine, by comparing the effects of single intake of the two drugs to placebo in reducing symptoms of seasonal allergic rhinitis (SAR) in ragweed sensitive adult subjects exposed to ragweed pollen in an Environmental Exposure Unit.

Timeline

Start
2006-01-01
Primary completion
2006-04-01
Completion
2006-04-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Cetirizine Other / unclassified 5 mg Oral
Subject Cetirizine Other / unclassified 10 mg Oral
Subject Levocetirizine Unknown 2.5 mg Oral
Subject Levocetirizine Unknown 5 mg Oral